PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1-98 AND ATAC TRIALS-A UK PERSPECTIVE
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71967-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)71967-2/fulltext
Title :
PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1-98 AND ATAC TRIALS-A UK PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71967-2&doi=10.1016/S1098-3015(11)71967-2
First page :
A264
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
123